RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 78-88
  • AbbVie wins 3-company battle to buy cancer drugmaker for $21B

    AbbVie wins 3-company battle to buy cancer drugmaker for $21B
    Three bidders remained at the last hour, but North Chicago-based AbbVie walked away the winner late Wednesday to buy a California company and its expected blockbuster blood cancer drug. "I've been through a lot of these, and I'd say this was probably one...
  • MedImmune tapping local partners to speed discoveries

    MedImmune tapping local partners to speed discoveries
    The story of MedImmune, the Maryland startup that British pharmaceutical giant AstraZeneca bought for $15.6 billion in 2007, is an example for entrepreneurs striving for their own blockbuster deals. But MedImmune leaders say they want to go beyond leading...
  • Baxter spinoff to make home in Bannockburn

    Baxter International said Monday its spinoff pharmaceutical company Baxalta will be located in north suburban Bannockburn, not far from Baxter's headquarters in Deerfield. "Selecting Baxalta's global headquarters is a key milestone on our journey to...
  • AbbVie to buy leukemia drug maker Pharmacyclics for $21 billion

    AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics and add another major revenue producer to a portfolio that already includes the world's top-selling drug. The deal will give the North Chicago, Ill., drugmaker Imbruvica, a blood...
  • Advocates Seek New Laws Promoting Drugs That Deter Abuse

    Advocates Seek New Laws Promoting Drugs That Deter Abuse
    Mary Marcuccio knows all about the toll of opiate abuse: Her son became addicted to prescription painkillers that he first obtained from a friend's medicine cabinet. "Our story is typical," said Marcuccio, a former Southington resident who runs a...
  • Pfizer to pay $17 billion for Hospira Inc.

    Pfizer to pay $17 billion for Hospira Inc.
    Pfizer Inc. led the deal-making in the interconnected pharmaceuticals industry Thursday, saying it would buy Hospira Inc. for about $17 billion, including debt. Hospira is a leader in the generic injectable-medicine market and is among those at the...
  • Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016

    Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016
    A Northbrook company said it has won fast-track status for approval of a drug that could become the first in the United States to treat Duchenne muscular dystrophy, a fatal muscle disease found most often in boys. Privately held Marathon Pharmaceuticals...
  • Uber, Carnegie Mellon partnering on driverless car research

    Uber, Carnegie Mellon partnering on driverless car research
    PITTSBURGH — Ride-sharing service Uber is partnering with Carnegie Mellon University on a Pittsburgh research lab both hope could lead to the development of driverless cars. Carnegie Mellon and its Robotics Institute have been working on...
  • Reduce your drug costs instantly with these simple changes

    As health insurers shift more of the cost burden to consumers, the average U.S. worker with employer-provided coverage now pays $9,695 per year in premiums and out-of-pocket costs for a family of four -- a 118 percent increase over the past decade,...
  • Mann steps down as CEO of inhaled insulin maker MannKind Corp.

    Mann steps down as CEO of inhaled insulin maker MannKind Corp.
    Alfred Mann, the billionaire entrepreneur and inventor behind several successful medical device companies, is stepping down as chief executive of MannKind Corp., a Valencia maker of inhaled insulin. Mann, 89, the founder and chief financial backer of...
  • AbbVie's breakup with Shire torpedoes 4th quarter, 2014 results

    AbbVie's breakup with Shire torpedoes 4th quarter, 2014 results
    AbbVie's fourth-quarter and 2014 earnings were defined by an engagement to Irish drugmaker Shire that quickly crumbled. The North Chicago-based biopharmaceutical spinoff from Abbott Laboratories beat expectations on adjusted figures but took a blow...